Dr Claire Roddie and UCLH CAR T team have organised this meeting to discuss CAR T cell therapy in the non-malignant disease areas of Rheumatology and Neurology to include MS, MG, lupus, SS and myositis patient pathways.
Suitable for anyone working in this area.
Date: Friday 27 September
Venue: Hallam Conference Centre, 44 Hallam Street, London W1W 6JJ
Aims:
- Creation a CAR T cell therapy day to discuss issues which impact rheumatology and neurology areas of treatment and autoimmunity.
- Enable sharing best practice from across the UK and with an International expert opinion.
- To satisfy unmet needs in the diagnosis, research and treatment pathways of CAR T cell therapy for autoimmune diseases.
Topics to include:
- Trials updates for CAR T in autoimmune disease
- Real World Experience - Rheumatology speaker from University Hospital Erlangen
- Sequencing of treatment, transplant and CAR T
- Eligibility and selection of rheumatology patients
- Eligibility and selection of neurology patients
- The route to CAR T and the practicalities to consider
- Toxicity management and ICU
- Shared care considerations for CAR T pre and post procedure
Case studies
https://hartleytaylor-registration.co.uk/docs/CARKprog.pdf
